Neurodegeneration – News and Features

AppTec to manufacture multiple sclerosis drug candidate for toxicology studies and clinical trial using ACE System.

Patent Covers Any Chemically Modified siRNA Sequence Used Against the Targeted Gene and Sets Precedent for Sirna Therapeutics' Substantial Target Patent Portfolio in the U.S.

Wyeth Pharmaceuticals and the Health Ministry of Scotland have announced in Edinburgh the creation of the Translational Medicine Research Collaboration (TMRC).

A combination of Pharming with DNage will generate important synergies in the area of business development and management expertise.

Metabolon's technology is being applied to numerous disease categories and across multiple stages of research.

This round will enable the company to accelerate the development of its antifungal compounds.

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.

The researchers show how people's genes play a role in their response to stress in their environment.

Roche and MorphoSys will collaborate on two new antibody programs in oncology.

British researchers identified variations in SRY gene levels may be linked to the onset of Parkinson's.